Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>NTG is a high-growth IT services and software company, providing solutions to large enterprise clients in Saudi Arabia.</li>
<li>The Company provides direct exposure to the economic growth of Saudi Arabia which is investing US$1.3T in its Vision 2030 plan.</li>
<li>NTG has seen margins dip in 2025 due to expanding its workforce, however, we expect margin expansion going forward.</li>
</ul>


NTG is a high-growth IT services and software company, providing solutions to large enterprise clients in Saudi Arabia.
The Company provides direct exposure to the economic growth of Saudi Arabia which is investing US$1.3T in its Vision 2030 plan.
NTG has seen margins dip in 2025 due to expanding its workforce, however, we expect margin expansion going forward.


NCI: High Growth and Increasing Margins Meets Compelling Valuation

NTG Clarity Networks

NCI: High Growth and Increasing Margins Meets Compelling Valuation